We are live on ! Find out more
KNTE

Kinnate Biopharma Inc. Common Stock

Delisted

KNTE was delisted on the 2nd of April, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
FCMI
1
Foresite Capital Management IV
California
$223M
O
2
OrbiMed
New York
$88.6M
RCM
3
RA Capital Management
Massachusetts
$82.7M
VVA
4
Vida Ventures Advisors
Massachusetts
$63.2M
Fidelity Investments
5
Fidelity Investments
Massachusetts
$48.3M -$167K -7,675 -0.4%
BlackRock
6
BlackRock
New York
$43.1M +$13.1M +600,832 +47%
Vanguard Group
7
Vanguard Group
Pennsylvania
$42.9M +$14.6M +672,778 +57%
BC
8
Boxer Capital
California
$42.5M +$17M +781,620 +73%
Viking Global Investors
9
Viking Global Investors
Connecticut
$41.9M
VA
10
VR Adviser
New York
$33.9M
Citadel Advisors
11
Citadel Advisors
Florida
$26.6M -$3.19M -146,614 -11%
DM
12
Deerfield Management
New York
$23.7M +$185K +8,508 +0.8%
FCMV
13
Foresite Capital Management V
California
$20.1M
NHAS
14
Novo Holdings A/S
Denmark
$11.5M +$4.32M +198,528 +66%
HMC
15
Harvard Management Company
Massachusetts
$11.5M
Morgan Stanley
16
Morgan Stanley
New York
$9.27M +$6.88M +315,822 +363%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$7.76M +$2.18M +99,973 +42%
RSCM
18
Rock Springs Capital Management
Maryland
$7.67M +$30.5K +1,400 +0.4%
State Street
19
State Street
Massachusetts
$7.66M +$2.08M +95,445 +40%
Federated Hermes
20
Federated Hermes
Pennsylvania
$7.09M
PHS
21
PFM Health Sciences
California
$6.08M
WP
22
Woodline Partners
California
$5.99M
Northern Trust
23
Northern Trust
Illinois
$4.87M +$1.65M +75,840 +56%
EC
24
EcoR1 Capital
California
$4.03M +$3.27M +150,000 +600%
American Century Companies
25
American Century Companies
Missouri
$4M +$1.55K +71 +0%